GINA SETTLE: Open Payments
NPI 1730335506 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,430 in 72 payments from 20 companies in 2025. Trend: 2023 $1,815 · 2024 $1,030 · 2025 $1,430
Food & beverage: $1,430
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 8 | $208 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $173 |
| Noven Therapeutics, LLC | 9 | $158 |
| Teva Pharmaceuticals USA, Inc. | 5 | $110 |
| Vanda Pharmaceuticals Inc. | 5 | $103 |
| Bausch Health US, LLC | 4 | $94 |
| Collegium Pharmaceutical, Inc. | 5 | $92 |
| Corium, LLC | 6 | $89 |
| Alkermes, Inc. | 3 | $68 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 | $61 |
Products named: Auvelity, CAPLYTA, Xelstrym, AUSTEDO XR, FANAPT, APLENZIN, Jornay PM, REXULTI.
Industry payments across KY — which companies pay providers there.
